Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kauffman Michael
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   800,347    

Indirect Shares

   898,131      
Direct Value   $776,138    

Indirect Value

   $870,379      
Total Shares   1,698,478      
Total Value   $1,646,517      


Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $691,702 Verastem, Inc. $31,680 Kezar Life Sciences, Inc. $44,201 Adicet Bio, Inc $8,555 Onyx Pharmaceuticals Inc $0 Karyopharm Therapeutics Inc. $691,702 Verastem, Inc. $31,680 Kezar Life Sciences, Inc. $44,201 Adicet Bio, Inc $8,555
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    12    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    12    
   
     Gain/Loss Ratio :
   0.0   
   -12.0   
     Percentage Gain/Loss :
     0.0%
 -553.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Onyx Pharmaceuticals Inc ONXX Chief Medical Officer 2010-02-09 9,000 2009-11-16 0    Premium*  
            Karyopharm Therapeutics Inc. KPTI Director 2022-02-28 713,757 2022-02-28 898,131    Premium*  
            Verastem, Inc. VSTM Director 2018-09-28 8,000 2014-09-17 0    Premium*  
            Kezar Life Sciences, Inc. KZR Director 2022-01-03 63,690 2018-06-25 0    Premium*  
            Adicet Bio, Inc ACET Director 2023-06-01 5,900 2023-06-01 0    Premium*  
* Premium Members only  

Records found :    156         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-09-16 4 OE $4.75 $47,520 D/D 10,000 539,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-01 4 AS $12.00 $120,000 I/I (10,000) 731,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-01 4 OE $4.75 $47,520 I/I 10,000 741,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-01 4 OE $4.75 $47,520 D/D 10,000 539,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-01 4 AS $12.00 $120,000 D/D (10,000) 529,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-08 4 AS $14.63 $146,254 I/I (10,000) 731,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-08 4 OE $4.75 $47,520 I/I 10,000 741,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-11 4 OE $4.75 $47,520 D/D 10,000 539,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-11-11 4 AS $14.76 $147,610 D/D (10,000) 529,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-12-09 4 AS $17.02 $170,210 I/I (10,000) 731,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-12-09 4 OE $4.75 $47,520 I/I 10,000 741,134 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-12-10 4 OE $4.75 $47,520 D/D 10,000 539,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-12-10 4 AS $15.99 $159,896 D/D (10,000) 529,767 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2019-12-19 4 GD $0.00 $0 I/I 34,626 0 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-01-08 4 OE $4.75 $47,520 I/I 10,000 753,506 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-01-08 4 AS $18.57 $185,705 I/I (10,000) 743,506 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-01-09 4 OE $4.75 $47,520 D/D 10,000 552,139 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-01-09 4 AS $19.19 $191,880 D/D (10,000) 542,139 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-10 4 AS $16.93 $169,327 I/I (10,000) 743,506 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-10 4 OE $4.75 $47,520 I/I 10,000 753,506 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-11 4 AS $17.43 $174,294 D/D (10,000) 542,139 0 %
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-11 4 OE $4.75 $47,520 D/D 10,000 552,139 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-15 4 OE $0.00 $0 I/I 21,800 765,306 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-15 4 OE $0.00 $0 D/D 21,800 563,939 0 -
KPTI Karyopharm Therapeutics I... Chief Executive Officer   •       •      –    2020-02-19 4 S $16.48 $145,321 D/D (8,817) 555,122 0 %
  156  Records found
  1   2   3   4  5   6   7      
  Page 4 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us